Urology faces a 16% projected workforce shortfall by 2038 -- with HRSA projecting only 84% adequacy -- while median compensation reaches $529,858 and each urologist generates approximately $1,800,000 in annual revenue, making single-vacancy losses of $2.4-$3.1 million over a 344-day historical time-to-fill among the costliest in medicine (Source: HRSA, 2025; MGMA, 2024; AMN Healthcare, 2023; CompHealth, 2024; AAPPR, 2024). The AUA residency match achieves a 100% fill rate with zero vacancies nationally, and applicants submit an average of 54 applications per candidacy (Source: AUA, 2025). Talyx's physician intelligence graph tracks 66,887 physicians across all 50 U.S. states and 61,944 healthcare facilities, delivering the data-driven pipeline intelligence urology recruitment demands.
Urology faces one of the most persistent and severe workforce shortfalls in medicine. HRSA projects only 83% workforce adequacy by 2035 and 84% by 2038 -- a 16% shortfall that has remained stubbornly consistent across modeling cycles, unlike other specialties that show either improvement or deterioration (Source: HRSA, 2022; HRSA, 2025).
The urology workforce deficit carries national implications. This 16% projected shortfall ties urology with cardiology as the most shortage-affected specialty in the HRSA framework. The AAMC projects a total physician shortage of 13,500 to 86,000 by 2036, with surgical specialties projected to face a shortfall of 10,100 to 19,900 physicians (Source: AAMC, 2024). Urology, as a surgical specialty with a significant aging physician population, absorbs a disproportionate share of this deficit.
The demand driver is demographic: urology conditions -- prostate disease, kidney stones, bladder dysfunction, urologic cancers -- increase sharply with age. The 65+ U.S. population is projected to grow 34.1% and the 75+ population 54.7% by 2036, directly expanding the patient volume that urologists must serve (Source: AAMC, 2024).
| Metric | Value | Source |
|---|---|---|
| MGMA Median Total Compensation | $529,858 | MGMA 2024 Report |
| Doximity Average Compensation | $559,474 | Doximity 2025 Report |
| Year-over-Year Growth | +1.40% (essentially flat) | NEJM CareerCenter, 2024 |
| Median Annual wRVUs | 7,000-8,000 | Marit Health, 2025 |
| $/wRVU Rate | $66-76 | Marit Health, 2025 |
| Annual Revenue Generated | ~$1,800,000 | AMN Healthcare, 2023 |
Urology compensation growth of only 1.40% year-over-year is essentially flat -- among the lowest growth rates of any surgical specialty and below the overall physician compensation growth rate of 3.7% (Source: MGMA, 2024; Doximity, 2025). Despite modest compensation growth, urologists generate approximately $1,800,000 in annual revenue, representing a significant revenue multiplier relative to their compensation (Source: AMN Healthcare, 2023).
Urology operates its own match through the American Urological Association (AUA), separate from the NRMP Main Match. The 2025 urology match achieved a 100% position fill rate -- all 403 positions filled with zero vacancies (Source: AUA, 2025). Key match statistics reveal the extreme competitiveness of the pipeline:
(Source: AUA, 2025)
The combination of 100% fill rate and 76% applicant match rate means the urology pipeline is operating at maximum capacity with excess applicant demand -- a pattern that ensures no expansion of supply without new residency positions.
Urologists generate approximately $1,800,000 in annual revenue, with practice economics driven by a mix of office-based procedures, surgical cases, and ancillary services (Source: AMN Healthcare, 2023). Urology practices with owned ambulatory surgery centers for procedures such as lithotripsy, ureteroscopy, prostate biopsies, and minimally invasive prostate surgery capture facility fees that amplify per-physician revenue.
At vacancy revenue losses of $7,000-$9,000 per day and a historical urology time-to-fill of 344 days (2022 data, among the longest reported for any specialty), a single urology vacancy represents $2.4 million to $3.1 million in lost revenue (Source: CompHealth, 2024; AAPPR, 2024).
Physician turnover costs of $750,000 to $1.8 million per departure apply with particular intensity in urology, where the long time-to-fill extends the period of lost revenue and increases interim locum tenens costs (Source: Premier Inc., 2024).
PE investment in urology has accelerated as investors recognize the specialty's favorable economics: an aging patient population driving predictable demand growth, procedure-intensive practice models generating high per-physician revenue, and ancillary service integration opportunities through ASCs and imaging facilities.
PE healthcare deal value reached $115 billion globally in 2024, with add-on acquisitions outnumbering platform buyouts nearly 4:1 (621 vs. 166 across all healthcare) (Source: Bain & Company, 2025; PESP, 2025). Talyx monitors 742 PE firms active in healthcare, tracking portfolio composition and exit timing patterns that inform urology platform competitive strategy. Urology platforms actively pursue add-on acquisitions to build geographic density, and each acquisition requires both physician retention and additional recruitment to support growth.
Mid-size practices ($1-5M EBITDA) typically trade at 8-12x EBITDA, while large platforms command mid-teens multiples (Source: FOCUS Investment Banking, 2025). Practices with owned ASCs, advanced robotic surgery capabilities, and strong commercial payer mixes command premium valuations.
NPI Registry and CMS Utilization Data: Taxonomy code filtering for urology (208800000X) and subspecialties including urologic oncology, female pelvic medicine, and pediatric urology. CMS Part B data reveals procedure volumes, surgical case mix (robotic prostatectomy, lithotripsy, cystoscopy, biopsy), and Medicare billing patterns.
AUA Match and Fellowship Pipeline: AUA Match statistics (100% fill rate, 403 positions), fellowship tracking for urologic oncology, female pelvic medicine, pediatric urology, and minimally invasive/robotic surgery. Academic program graduation data provides 12-18 month advance intelligence on new workforce entrants.
Robotic Surgery and Technology Adoption: da Vinci console assignment data, hospital robotic surgery program directories, and CME activity in robotic techniques identify urologists with advanced procedural capabilities -- increasingly important as robotic prostatectomy and cystectomy become standard of care.
ASC Ownership and Facility Data: State ASC licensing records, CMS facility enrollment, and ownership filings identify urologists with ambulatory surgery center equity -- relevant for both acquisition targeting and recruitment leverage assessment.
Professional Society Monitoring: AUA, SUFU (Society of Urodynamics, Female Pelvic Medicine), and SUO (Society of Urologic Oncology) membership, leadership positions, and meeting presentations reveal subspecialty expertise and professional network positioning.
SOCMINT and Mobility Indicators: LinkedIn, Doximity, and practice website analysis for career trajectory, geographic preferences, and professional activity patterns that indicate openness to practice transitions.
Among the Longest Time-to-Fill of Any Specialty: Urology reported a 344-day time-to-fill based on 2022 AAPPR data, placing it among the most prolonged recruitment cycles in medicine (Source: AAPPR, 2024). Only oncology (332 days in 2024 data) and neurosurgery (254 days) approach comparable timelines.
100% Residency Fill Rate with Zero National Vacancies: The AUA Match fills every available position with zero vacancies, and 76% of applicants match -- indicating both maximum pipeline capacity and excess demand for training slots (Source: AUA, 2025). Supply cannot expand without new residency positions.
Aging Patient Demographics Accelerating Demand: Urologic conditions -- prostate cancer, benign prostatic hyperplasia, kidney stones, bladder dysfunction -- are strongly age-correlated. The 75+ population growing 54.7% by 2036 will drive substantial demand increases for urology services, intensifying the existing 16% supply shortfall (Source: AAMC, 2024).
Robotic Surgery Capability Requirements: An increasing proportion of urologic procedures -- particularly prostatectomy, cystectomy, and partial nephrectomy -- are performed robotically. Recruiting urologists without robotic surgery training or experience limits their procedural scope and reduces their platform value, yet robotically trained urologists command premium compensation.
Flat Compensation Growth Limiting Recruitment Levers: Urology's 1.40% year-over-year compensation growth is essentially flat, reducing the traditional recruitment lever of offering above-market compensation (Source: MGMA, 2024). PE platforms must compete on practice model, call schedule, ASC equity participation, and robotic surgery access rather than compensation alone.
| Metric | Description | Intelligence Value |
|---|---|---|
| Surgical Case Volume | Annual case counts by category (prostate, stone, oncology, reconstruction) | Revenue capacity and subspecialty proficiency |
| Robotic Surgery Utilization | da Vinci console time, robotic case volumes, procedure types | Advanced capability assessment and platform compatibility |
| ASC Ownership and Utilization | Equity position in ambulatory surgery facilities and case volume | Recruitment leverage and acquisition compatibility |
| Office-Based Procedure Volume | Cystoscopy, biopsy, vasectomy, UroLift, and other in-office cases | Revenue density and practice efficiency |
| Referral Network Analysis | PCP and specialist referral patterns, geographic coverage | Revenue stability and growth trajectory |
| Payer Mix and Reimbursement Profile | Commercial vs. Medicare distribution; managed care participation | Revenue quality assessment |
| Subspecialty Certification | Urologic oncology, female pelvic medicine, pediatric urology | Candidate-role fit and service line expansion potential |
| Career Stage and Retirement Indicators | Age, practice ownership, succession planning signals | Pipeline planning and timing assessment |
Urologist Candidate Dossiers: Talyx's physician intelligence infrastructure provides urology-specific recruitment and retention analytics. Multi-source profiles integrate CMS utilization data, surgical volume analysis, robotic surgery capabilities, ASC ownership records, professional network positioning, and behavioral mobility indicators.
AUA Match and Fellowship Pipeline Reports: Talyx's fellowship pipeline intelligence tracks 103 candidates graduating between 2025-2027 (45 in 2025, 49 in 2026, 9 in 2027) across tracked specialties. Annual analysis covers urology residency and fellowship graduates, including geographic distribution, subspecialty interests, robotic training levels, and early career trajectory signals.
Urology Market Demand Analysis: MSA-level intelligence combining HRSA workforce projections (84% adequacy), population age demographics, existing urologist density, and competitive platform presence to identify optimal recruitment and expansion geographies. According to Talyx intelligence data, California (6,609 physicians), Florida (1,945), Texas (1,758), New York (1,331), and Pennsylvania (938) represent the five largest physician markets in Talyx's intelligence graph, geographic concentrations essential for urology expansion planning.
ASC and Facility Intelligence: Market-level analysis of urology-relevant ASC capacity, ownership structures, case volumes, and expansion potential -- informing both recruitment value propositions and facility investment decisions.
Competitive Platform Monitoring: Ongoing intelligence on competing urology MSOs and PE-backed platforms, tracking acquisition activity, physician recruitment campaigns, compensation positioning, and geographic expansion.
Retention Risk Assessment: Continuous monitoring of employed urologists for turnover indicators including new licensing activity, professional profile updates, practice ownership changes, and compensation gap analysis against current benchmarks. PE platforms using Talyx's intelligence infrastructure gain urology market visibility including compensation benchmarks, competitive positioning, and recruitment pipeline data. Talyx's capability transfer model ensures urology intelligence becomes a permanent organizational capability owned by the client.
Urology faces a persistent 16% workforce shortfall, with HRSA projecting only 83% adequacy by 2035 and 84% by 2038 -- tying with cardiology as the most shortage-affected specialty in the HRSA framework (Source: HRSA, 2022; HRSA, 2025). The demand driver is demographic: the 65+ population growing 34.1% and the 75+ population growing 54.7% by 2036 will increase prostate disease, urologic cancers, and kidney stone volumes (Source: AAMC, 2024). The AUA Match fills 100% of positions with zero national vacancies, meaning the training pipeline cannot expand without new residency slots (Source: AUA, 2025).
MGMA reports median total compensation of $529,858 for urologists, while Doximity reports $559,474, ranking urology 12th among all specialties (Source: MGMA, 2024; Doximity, 2025). Year-over-year growth of 1.40% is essentially flat -- among the lowest of any surgical specialty -- meaning PE platforms must compete on practice model, ASC equity, and robotic surgery access rather than compensation alone. Urologists generate approximately $1,800,000 in annual organizational revenue at 7,000-8,000 wRVUs and $66-76 per wRVU (Source: AMN Healthcare, 2023; Marit Health, 2025).
Talyx monitors AUA Match data, fellowship pipelines, NPI registry changes, and CMS utilization to identify urology candidates 12-18 months before they enter active job searches -- bypassing the 344-day median time-to-fill that makes each vacancy a $2.4-$3.1 million revenue loss. Talyx classifies physicians into priority tiers (320 high/very-high priority, 17,729 medium-priority, 2,832 low-priority) for precise campaign targeting. For urology platforms pursuing add-on acquisitions, Talyx scores targets on physician demographics, ASC economics, referral stability, and competitive positioning.
Schedule a strategic briefing to discuss how Talyx can build intelligence infrastructure for your organization.
Schedule a Briefing